Dr. Marchetti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2320 Freeway Dr
Mount Vernon, WA 98273Phone+1 360-814-6800Fax+1 646-227-7274
Education & Training
University of Virginia Medical CenterResidency, Dermatology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2009 - 2010
Johns Hopkins University School of MedicineClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
WA State Medical License 2023 - 2025
NY State Medical License 2013 - 2024
NJ State Medical License 2020 - 2023
VA State Medical License 2010 - 2013- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 13 citationsEarly Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.Mohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, Jack L Arbiser, Elizabeth G Berry
JAMA Dermatology. 2023-05-01 - 16 citationsProspective validation of dermoscopy-based open-source artificial intelligence for melanoma diagnosis (PROVE-AI study).Michael A Marchetti, Emily A Cowen, Nicholas R Kurtansky, Jochen Weber, Megan Dauscher
NPJ Digital Medicine. 2023-07-12 - 11 citationsUtility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.Michael A Marchetti, Stephen W Dusza, Edmund K Bartlett
JAMA Dermatology. 2022-06-01
Journal Articles
- Dermoscopy Proficiency Expectations for US Dermatology Resident PhysiciansLaura K Ferris, Natalia Jaimes, John C Kawaoka, Caroline C Kim, Sancy A Leachman, Patricia Lucey, Michael A Marchetti, Ashfaq A Marghoob, Edward Prodanovic, Elizabeth ..., JAMA Dermatology
- Incidence of New Primary Cutaneous Melanoma in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitorsAshfaq A Marghoob, Michael A Marchetti, JAMA Dermatology
- Performance of Gene Expression Profile Tests for Prognosis in Patients with Localized Cutaneous MelanomaMichael A Marchetti, Silvia E Mancebo, JAMA Dermatology
- Join now to see all
Authored Content
- Performance of Gene Expression Profile Tests for Prognosis in Patients with Localized Cutaneous MelanomaJuly 2020
- Performance of Gene Expression Profile Tests for Prognosis in Patients with Localized Cutaneous MelanomaJuly 2020
- Performance of Gene Expression Profile Tests for Prognosis in Patients with Localized Cutaneous MelanomaJuly 2020
- Association of Multiple Aggregated Yellow-White Globules with Nonpigmented Basal Cell CarcinomaMay 2020
- Association of Multiple Aggregated Yellow-White Globules with Nonpigmented Basal Cell CarcinomaMay 2020
- Join now to see all
Press Mentions
Routine Skin Checks Do Not Reduce Melanoma-Specific MortalityNovember 5th, 2021- GEP Tests Fail to ID Recurrence Risk in Cutaneous MelanomaJuly 30th, 2020
Imaging Technologies Improve Melanoma DiagnosisJanuary 14th, 2016- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
